Viewing Study NCT05019534


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-27 @ 11:38 PM
Study NCT ID: NCT05019534
Status: UNKNOWN
Last Update Posted: 2022-05-19
First Post: 2021-08-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
Sponsor: West China Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module